Our goal was to find small molecules directed to the interface residues between KRas4B and PDE6δ through virtual screening in order to promote a more stable union between the targets of these molecules and evaluate their impact on KRas4B signaling in vitro and on a tumor model in vivo. Here, PDE6D is linked to neoplasm.